Reaction
Embolic Cerebral Infarction reporting signals
As of the last recalculation, Embolic Cerebral Infarction appears in 658 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is RIVAROXABAN (PRR 32.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rivaroxaban | 163 | 32.6 | 32.6 |
| Pitavastatin Calcium | 10 | 31.4 | 31.4 |
| Rifampicin | 7 | 22.1 | 22.1 |
| Amikacin | 11 | 20.7 | 20.7 |
| Amphotericin B | 8 | 20.4 | 20.4 |
| Dabigatran Etexilate Mesylate | 40 | 18.5 | 18.5 |
| Dabigatran Etexilate | 40 | 17.3 | 17.3 |
| Aflibercept | 6 | 6.1 | 6.1 |